MS-Based HLA-II Peptidomics Combined With Multiomics Will Aid the Development of Future Immunotherapies

Immunotherapies have emerged to treat diseases by selectively modulating a patient’s immune response. Although the roles of T and B cells in adaptive immunity have been well studied, it remains difficult to select targets for immunotherapeutic strategies. Because human leukocyte antigen class II (HL...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Hannah B., Klaeger, Susan, Clauser, Karl R., Sarkizova, Siranush, Weingarten-Gabbay, Shira, Graham, Daniel B., Carr, Steven A., Abelin, Jennifer G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327157/
https://www.ncbi.nlm.nih.gov/pubmed/34146720
http://dx.doi.org/10.1016/j.mcpro.2021.100116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327157/
https://www.ncbi.nlm.nih.gov/pubmed/34146720
http://dx.doi.org/10.1016/j.mcpro.2021.100116

Ejemplares similares